NCT02472288

Brief Summary

This study aimed to evaluate the effectiveness of adjuvant electroacupuncture therapy for the post-stroke patients with urinary retention under conventional treatments, compared with sham electroacupuncture.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2015

Geographic Reach
1 country

3 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 9, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 15, 2015

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2016

Completed
Last Updated

August 31, 2016

Status Verified

August 1, 2016

Enrollment Period

1 year

First QC Date

June 9, 2015

Last Update Submit

August 29, 2016

Conditions

Keywords

urinary retentionpoststrokeelectroacupuncturerandomized controlled trialeffectivenesssafety

Outcome Measures

Primary Outcomes (1)

  • Change of daily PVR (Postvoid Residual) urine ratios between the baseline and the endpoint

    * daily PVR ratio = daily PVR urine volume / (daily PVR urine volume + self voiding volume) * Baseline measurement: daily PVR ratio for 24 hours on the day before the first intervention day Endpoint measurement: daily PVR ratio for 24 hours within 3 days after the last intervention day * If more than 7 sessions of EA or sham EA are completed and urinary tract is not infected at the end, then the urine volume is measured on the next day of the last intervention. * If more than 7 sessions of EA or sham EA are completed and urinary tract is infected at the end, then the urine volume is measured on the 3rd day of the last intervention after anti-infection treatment is carried out for 48 hours.

    Day 0 (baseline), Day 14(endpoint)

Secondary Outcomes (6)

  • Urinary tract infection (UTI)

    Day 14(endpoint)

  • Korean version of Qualiveen Questionnaire (K-QQ)

    Day 0 (baseline), Day 14(endpoint)

  • Korean version of International Prostate Symptom Scale (K-IPSS)

    Day 0 (baseline), Day 14(endpoint)

  • Blinding Index (BI)

    Day 14(endpoint)

  • Frequencies of urination and urinary incontinence

    Day 0 (baseline), Day 14(endpoint)

  • +1 more secondary outcomes

Other Outcomes (1)

  • Diabetes mellitus (DM) and benign prostatic hyperplasia (BPH)

    Day 0 (baseline)

Study Arms (2)

Electroacupuncture (EA) group

EXPERIMENTAL

1. Electroacupuncture therapy (10 sessions in total, 5 per a week, 2 weeks) 2. BL31, BL32, BL33, and BL34 (total 8 acupoints, bilateral) 3. 20 minutes duration, middle frequency (30 Hz) of electrical stimulation 4. conventional treatments permitted

Device: Electroacupuncture (EA)

Sham group

SHAM COMPARATOR

1. Non-penetrating Park sham electroacupuncture treatment (10 sessions in total, 5 per a week, 2 weeks) 2. BL31, BL32, BL33, and BL34 (total 8 acupoints on the right and left sides) 3. 20 minutes duration, undelivered electrostimulation of middle frequency (30 Hz) 4. conventional treatments permitted

Device: Sham electroacupuncture

Interventions

The EA group receives 10 sessions of EA therapy (5 per a week, 2 weeks). After inserting needles by 5-10 mm (stainless steel, 0.25 mm in diameter and 4.0 mm in length, Dong Bang Acupuncture Inc., Korea) using the Park sham guide tube on the 8 points (BL31, BL32, BL33, and BL34, bilateral sides), de qi response is elicited. The electrical stimulation is then presented for 20 minutes by middle frequency (30 Hz) (STN-111, Stratek, Korea). Conventional treatments (western/traditional herbal medications, rehabilitation, or acupuncture without electro-stimulation for stroke, and western/traditional herbal medications or acupuncture without electro-stimulation for urinary retention) are allowed during the intervention period. The practitioner should have over 1-year clinical experiences.

Electroacupuncture (EA) group

The patients in sham group receive totally 10 sessions of the sham EA (5 sessions per a week, for 2 weeks). Non-penetrating needles of Park sham device are implemented on the bilateral points of BL31, BL32, BL33, and BL34 (total 8 acupoints). Then, the electro-stimulation is presented for 20 minutes by middle frequency (30 Hz) (STN-111, Stratek, Korea), even though the electrical stimulation is not delivered through the skin. Conventional treatments for stroke and urinary retention along with EAT are not eliminated. It is also necessary for the practitioner with more than 1-year experiences on the clinical field.

Sham group

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • male or female aged over 19
  • Patients diagnosed with stroke (cerebral hemorrhage or infarction) based on the CT or MRI examination
  • Those whose onset is within 2 years
  • Those who have urinary retention after stroke onset (every PVR result is equal or more than 100ml on the 2 consecutive tests)
  • Those who signed on the informed consent form

You may not qualify if:

  • Patients who have any bleeding disorders based on medical history hearing
  • Patients who have ever had any medical procedures or surgeries for peripheral vascular diseases based on medical history hearing
  • Patients who have any psychiatry disorders based on medical history hearing
  • Patients who have any severe diseases in lower urinary tract symptom based on medical history hearing
  • Patients who have any acute or chronic infectious diseases in lower urinary tract symptom based on medical history hearing
  • Acute stage stroke patients (onset within 1 week) whose Glasgow Coma Scale ≤ 8
  • Patients who have fear about acupuncture
  • Patients who have changed medications for urinary retention or relevant symptoms, such as urinary incontinence drugs or diuretics, within 3 days
  • Female who diagnosed with pregnancy by urinalysis
  • Those who primary or sub investigators judge not to be suitable for the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Cheonan Korean Medicine Hospital of the Daejeon University

Cheonan, Chungcheongnam-do, 331-958, South Korea

Location

Dongguk University Ilsan Oriental Hospital

Goyang-si, Gyeonggi-do, 410-773, South Korea

Location

Kyung Hee University Korean Medicine Hospital

Seoul, 156-853, South Korea

Location

Related Publications (20)

  • Kong KH, Young S. Incidence and outcome of poststroke urinary retention: a prospective study. Arch Phys Med Rehabil. 2000 Nov;81(11):1464-7. doi: 10.1053/apmr.2000.9630.

    PMID: 11083349BACKGROUND
  • Wu J, Baguley IJ. Urinary retention in a general rehabilitation unit: prevalence, clinical outcome, and the role of screening. Arch Phys Med Rehabil. 2005 Sep;86(9):1772-7. doi: 10.1016/j.apmr.2005.01.012.

    PMID: 16181941BACKGROUND
  • Wu P, Mills E, Moher D, Seely D. Acupuncture in poststroke rehabilitation: a systematic review and meta-analysis of randomized trials. Stroke. 2010 Apr;41(4):e171-9. doi: 10.1161/STROKEAHA.109.573576. Epub 2010 Feb 18.

    PMID: 20167912BACKGROUND
  • Brittain KR, Perry SI, Peet SM, Shaw C, Dallosso H, Assassa RP, Williams K, Jagger C, Potter JF, Castleden CM. Prevalence and impact of urinary symptoms among community-dwelling stroke survivors. Stroke. 2000 Apr;31(4):886-91. doi: 10.1161/01.str.31.4.886.

    PMID: 10753993BACKGROUND
  • Garrett VE, Scott JA, Costich J, Aubrey DL, Gross J. Bladder emptying assessment in stroke patients. Arch Phys Med Rehabil. 1989 Jan;70(1):41-3.

    PMID: 2916918BACKGROUND
  • Mizrahi EH, Waitzman A, Arad M, Blumstein T, Adunksy A. Bladder management and the functional outcome of elderly ischemic stroke patients. Arch Gerontol Geriatr. 2011 Sep-Oct;53(2):e125-8. doi: 10.1016/j.archger.2010.07.007. Epub 2010 Aug 12.

    PMID: 20708280BACKGROUND
  • Mustonen S, Ala-Houhala IO, Tammela TL. Long-term renal dysfunction in patients with acute urinary retention. Scand J Urol Nephrol. 2001 Feb;35(1):44-8. doi: 10.1080/00365590151030804.

    PMID: 11291687BACKGROUND
  • Curtis LA, Dolan TS, Cespedes RD. Acute urinary retention and urinary incontinence. Emerg Med Clin North Am. 2001 Aug;19(3):591-619. doi: 10.1016/s0733-8627(05)70205-4.

    PMID: 11554277BACKGROUND
  • Smith MD, Seth JH, Fowler CJ, Miller RF, Panicker JN. Urinary retention for the neurologist. Pract Neurol. 2013 Oct;13(5):288-91. doi: 10.1136/practneurol-2012-000478. Epub 2013 Mar 29.

    PMID: 23542501BACKGROUND
  • Datta SN, Chaliha C, Singh A, Gonzales G, Mishra VC, Kavia RB, Kitchen N, Fowler CJ, Elneil S. Sacral neurostimulation for urinary retention: 10-year experience from one UK centre. BJU Int. 2008 Jan;101(2):192-6. doi: 10.1111/j.1464-410X.2007.07282.x. Epub 2007 Oct 26.

    PMID: 17970787BACKGROUND
  • Kessler TM, La Framboise D, Trelle S, Fowler CJ, Kiss G, Pannek J, Schurch B, Sievert KD, Engeler DS. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis. Eur Urol. 2010 Dec;58(6):865-74. doi: 10.1016/j.eururo.2010.09.024. Epub 2010 Oct 1.

    PMID: 20934242BACKGROUND
  • Herr-Wilbert IS, Imhof L, Hund-Georgiadis M, Wilbert DM. Assessment-guided therapy of urinary incontinence after stroke. Rehabil Nurs. 2010 Nov-Dec;35(6):248-53. doi: 10.1002/j.2048-7940.2010.tb00055.x.

    PMID: 21140719BACKGROUND
  • Tong Y, Jia Q, Sun Y, Hou Z, Wang Y. Acupuncture in the treatment of diabetic bladder dysfunction. J Altern Complement Med. 2009 Aug;15(8):905-9. doi: 10.1089/acm.2009.0062.

    PMID: 19678782BACKGROUND
  • Yu KW, Lin CL, Hung CC, Chou EC, Hsieh YL, Li TM, Chou LW. Effects of electroacupuncture on recent stroke inpatients with incomplete bladder emptying: a preliminary study. Clin Interv Aging. 2012;7:469-74. doi: 10.2147/CIA.S37531. Epub 2012 Nov 8.

    PMID: 23152677BACKGROUND
  • Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974 Jul 13;2(7872):81-4. doi: 10.1016/s0140-6736(74)91639-0. No abstract available.

    PMID: 4136544BACKGROUND
  • Rowe TA, Juthani-Mehta M. Diagnosis and management of urinary tract infection in older adults. Infect Dis Clin North Am. 2014 Mar;28(1):75-89. doi: 10.1016/j.idc.2013.10.004. Epub 2013 Dec 8.

    PMID: 24484576BACKGROUND
  • Grigoryan L, Trautner BW, Gupta K. Diagnosis and management of urinary tract infections in the outpatient setting: a review. JAMA. 2014 Oct 22-29;312(16):1677-84. doi: 10.1001/jama.2014.12842.

    PMID: 25335150BACKGROUND
  • Bang H, Ni L, Davis CE. Assessment of blinding in clinical trials. Control Clin Trials. 2004 Apr;25(2):143-56. doi: 10.1016/j.cct.2003.10.016.

    PMID: 15020033BACKGROUND
  • Sagnier PP, MacFarlane G, Richard F, Botto H, Teillac P, Boyle P. Results of an epidemiological survey using a modified American Urological Association symptom index for benign prostatic hyperplasia in France. J Urol. 1994 May;151(5):1266-70. doi: 10.1016/s0022-5347(17)35229-1.

    PMID: 7512657BACKGROUND
  • Shin S, Lee J, Yoo J, Lim SM, Lee E. Electroacupuncture versus sham electroacupuncture for urinary retention in poststroke patients: study protocol for a multicenter, randomized controlled trial. Trials. 2016 Apr 12;17:197. doi: 10.1186/s13063-016-1315-3.

Related Links

MeSH Terms

Conditions

Urinary RetentionStroke

Interventions

Electroacupuncture

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Combined Modality TherapyTherapeuticsAcupuncture TherapyComplementary TherapiesElectric Stimulation TherapyPhysical Therapy ModalitiesRehabilitationTranscutaneous Electric Nerve StimulationAnalgesiaAnesthesia and AnalgesiaAnesthesia

Study Officials

  • Euiju Lee, Ph.D.

    Kyunghee University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 9, 2015

First Posted

June 15, 2015

Study Start

April 1, 2015

Primary Completion

April 1, 2016

Study Completion

April 1, 2016

Last Updated

August 31, 2016

Record last verified: 2016-08

Locations